Mitchell E. Horwitz

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee et al. · Blood · 2009 · 773 citations · Full text

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Bart L. Scott, Marcelo C. Pasquini, Brent R. Logan et al. · Journal of Clinical Oncology · 2017 · 649 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Optimal Regimen Intensity +16

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Christopher S. Hourigan, Laura W. Dillon, Gege Gui et al. · Journal of Clinical Oncology · 2019 · 428 citations · Full text

The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators

Michael Centola, Geryl Wood, David M. Frucht et al. · Blood · 2000 · 401 citations

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 304 citations · Full text

Cell Therapy, Gvhd Prophylaxis, Immunology +17